MRNA Jun 2024 105.000 call
| Previous Close | 47.95 |
| Open | 39.80 |
| Bid | 43.00 |
| Ask | 44.10 |
| Strike | 105.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 39.80 - 39.80 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.33k |
Barrons.comThe Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
What began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger selloff Wednesday. The stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed on Friday. The stumble in Moderna share price, Barron’s wrote Tuesday, comes as investors await updates on three key areas: the company’s experimental cancer vaccine being developed with Merck ; the respiratory syncytial virus vaccine the Food and Drug Administration is expected to approve in the next few days, and the avian flu virus circulating in domestic cattle.
ZacksNasdaq Tops 17K: 5 Best-Performing Stocks in ETF YTD
The Nasdaq Composite Index topped the 17,000 level for the first time. We have highlighted five best-performing stocks of QQQ this year that led the way higher in the portfolio.
Barrons.comModerna Stock Is Having Another Very Bad Day. Here’s Why.
The stock’s drop comes as Moderna awaits important developments involving its experimental cancer treatment, a new respiratory vaccine, and a possible avian flu vaccine under development.Read the full ...
